Issue |
BIO Web Conf.
Volume 123, 2024
The 1st International Seminar on Tropical Bioresources Advancement and Technology (ISOTOBAT 2024)
|
|
---|---|---|
Article Number | 02009 | |
Number of page(s) | 12 | |
Section | Bioresources in Food and Nutrition for a Healthier Future | |
DOI | https://doi.org/10.1051/bioconf/202412302009 | |
Published online | 30 August 2024 |
Acetylcholinesterase inhibition activity and phytochemical screening of red betel leaf (Piper crocatum Ruiz & Pav) as anti-dementia agents
1 Department of Biochemistry, Faculty of Mathematics and Natural Sciences, IPB University, 16680 Bogor, Indonesia
2 Halal Science Center, IPB University, 16129 Bogor, Indonesia
* Corresponding author: dimasandrianto@apps.ipb.ac.id
Alzheimer's Disease (AD) is a neurodegenerative condition that results in progressive cognitive deterioration. The AD therapeutic approach with acetylcholinesterase inhibitors aims to boost cognitive function by raising acetylcholine levels in synaptic neurons. Piper crocatum Rui & Pav has antioxidant and anti-inflammatory properties, suggesting its potential to alleviate AD symptoms. This research aims to investigate the inhibitory activity of acetylcholinesterase (AChE) in vitro and identify the active compounds present in the fractions of red betel leaf. The methods of this research are Ellman’s colorimetric method and Liquid Chromatography-Mass Spectrometry (LC-MS). The red betel leaf fractions demonstrated effective AChE inhibition, as reflected by their IC50 values: 11.0965 μg/ml (ethanol extract), 16.7908 μg/ml (ethyl acetate fraction), 23.7390 μg/ml (n-hexane fraction), and 41.0044 μg/ml (water fraction). The ethanol extract with the lowest IC50 value was analyzed by LC-MS. The result showed 200 active compounds, 28 of which had concentrations exceeding 0.5%. The predominant active compounds include flavonoids, steroids, polyphenols, alkaloids, phenolics, vitamins, and carboxylic acids. In conclusion, the ethanol extract of red betel leaf shows promising potential as an AChE inhibitor, suggesting its use as a therapeutic agent to enhance cognitive function in patients with Alzheimer's Disease.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.